News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Hallal David
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2023 |
4
| Hallal David (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 23,443 shares
@ $0 Granted 34,735 options to buy
@ $4.33, valued at
$150.4k
|
|
06/15/2023 |
4
| Hallal David (Director) has filed a Form 4 on iTeos Therapeutics, Inc.
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
05/12/2023 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 35,000 shares
@ $0 |
|
10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 400,000 shares
@ $7.3523, valued at
$2.9M
|
|
08/01/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 3,253,796 shares
@ $4.61, valued at
$15M
|
|
07/21/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 4,227 shares
@ $5.3295, valued at
$22.5k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Hallal David (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 9,945 shares
@ $0 Granted 29,640 options to buy
@ $7.33, valued at
$217.3k
|
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 65,725 shares
@ $3.6684, valued at
$241.1k
|
|
05/27/2022 |
4
| Hallal David (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 28,000 options to buy
@ $4.75, valued at
$133k
|
|
05/19/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 27,500 options to buy
@ $4.6, valued at
$126.5k
|
|
04/22/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 4,227 shares
@ $5.87, valued at
$24.8k
|
|
03/11/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 40,481 shares
@ $7.5537, valued at
$305.8k
Sold 25,244 shares
@ $7.3708, valued at
$186.1k
|
|
01/25/2022 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 17,100 shares
@ $8.0052, valued at
$136.9k
|
|
12/22/2021 |
4
| Hallal David (Director) has filed a Form 4 on iTeos Therapeutics, Inc.
Txns:
| Sold 50,000 shares
@ $43.57, valued at
$2.2M
Exercised 20,000 options to buy
@ $4.3, valued at
$86k
Exercised 30,000 options to buy
@ $2.95, valued at
$88.5k
|
|
06/22/2021 |
4
| Hallal David (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 15,000 options to buy
@ $33.74, valued at
$506.1k
|
|
06/21/2021 |
4
| Hallal David (Director) has filed a Form 4 on iTeos Therapeutics, Inc.
Txns:
| Granted 16,608 options to buy
@ $26.03, valued at
$432.3k
|
|
06/01/2021 |
4
| Hallal David (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 7,800 options to buy
@ $26.78, valued at
$208.9k
|
|
05/27/2021 |
4
| Hallal David (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 22,500 options to buy
@ $21.51, valued at
$484k
|
|
01/25/2021 |
4
| Hallal David (CEO) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 147,000 shares
@ $0 Granted 273,000 options to buy
@ $45.04, valued at
$12.3M
|
|
12/11/2020 |
4
| Hallal David (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 18,691 options to buy
@ $19, valued at
$355.1k
|
|
08/05/2020 |
4
| Hallal David (CEO) has filed a Form 4 on Allovir, Inc.
Txns:
| Converted 13,420,970 shares
@ $0 Converted 156,577 shares
@ $0 Converted 738,153 shares
@ $0 Converted 20,000,000 convertible preferred
@ $0 Converted 233,333 options to buy
@ $0 Converted 1,100,000 options to buy
@ $0 |
|
07/31/2020 |
4
| Hallal David (CEO) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 1,101,000 options to buy
@ $17, valued at
$18.7M
|
|
07/24/2020 |
4
| Hallal David (Director) has filed a Form 4 on iTeos Therapeutics, Inc.
Txns:
| Granted 16,608 options to buy
@ $19, valued at
$315.6k
|
|
06/18/2020 |
4
| Hallal David (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 13,000 options to buy
@ $17.65, valued at
$229.5k
Granted 7,000 options to buy
@ $17.65, valued at
$123.6k
|
|
09/20/2019 |
4
| Hallal David (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Gifted 2,000 shares
@ $0 |
|
05/23/2019 |
4
| Hallal David (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 10,158 options to buy
@ $21.21, valued at
$215.5k
|
|
06/26/2018 |
4
| Hallal David (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 20,316 options to buy
@ $21.62, valued at
$439.2k
|
|
08/10/2016 |
4
| Hallal David (CEO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 332 shares
@ $137.14, valued at
$45.5k
|
|
04/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/08/2016 |
4
| Hallal David (CEO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 619 shares
@ $143.81, valued at
$89k
Sold 10 shares
@ $145.05, valued at
$1.5k
Granted 41,136 shares
@ $0 Sold 110 shares
@ $145.01, valued at
$16k
Sold 400 shares
@ $144.45, valued at
$57.8k
Sold 300 shares
@ $143.45, valued at
$43k
Sold 712 shares
@ $142.35, valued at
$101.4k
Sold 3,710 shares
@ $141.4, valued at
$524.6k
Sold 1,490 shares
@ $140.49, valued at
$209.3k
Sold 337 shares
@ $138.02, valued at
$46.5k
Sold 117 shares
@ $139.18, valued at
$16.3k
|
|
10/30/2013 |
4
| Hallal David (EVP, Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Exercised 18,000 shares
@ $17.98, valued at
$323.6k
Sold 13,223 shares
@ $122.79, valued at
$1.6M
Sold 4,777 shares
@ $123.77, valued at
$591.2k
Exercised 30,000 shares
@ $17.98, valued at
$539.4k
Sold 22,037 shares
@ $122.79, valued at
$2.7M
Sold 7,963 shares
@ $123.77, valued at
$985.6k
Exercised 18,000 options to buy
@ $17.975, valued at
$323.6k
|
|
|
|
|